Sandrock Alfred 4

What Happened

• Alfred Sandrock, President, CEO and Director of Voyager Therapeutics (VYGR), sold 14,197 shares on Feb 24, 2026. The weighted-average sale price was $3.79 per share for total proceeds of about $53,807. This was a sale (not a purchase) and appears to be a routine sell-to-cover for tax withholding related to vested restricted stock units.

Key Details

• Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (timely filing).
• Shares sold: 14,197; weighted-average price reported: $3.79; total proceeds: $53,807.
• Price range: shares were sold in multiple trades at prices from $3.61 to $3.86 (per filing footnote).
• Footnote: Sales were made under a durable automatic sale instruction (adopted May 12, 2025) to effect a sell-to-cover election to satisfy tax withholding for RSUs that vested Feb 21, 2026; the sales were not discretionary.
• Shares owned after the transaction: not specified in the summary provided.

Context

• This was a tax-withholding (sell-to-cover) sale tied to RSU vesting, a common executive action that typically reflects tax obligations rather than a directional bet on the stock. The filing indicates the trades were automated and non-discretionary per the reporting person’s instruction.